Zobrazeno 1 - 10
of 11
pro vyhledávání: '"B A Barbara Silver"'
Autor:
Peter M. Mauch, L B A Stacie Hitchcock, Andrea K. Ng, K B A Brian Chang, B A Barbara Silver, H B A Kendall Backstrand
Publikováno v:
Cancer. 91:1213-1218
BACKGROUND Epitrochlear involvement in Hodgkin disease (HD) is a rare event, with only limited data available describing this unique presentation, its treatment, and long term outcome. METHODS Between 1968 and 1997, 1180 patients with clinical stage
Autor:
Laura Collins, Amiel Cooper, Judith Manola, Jay R. Harris, Janice A. Lyons, Stella Hetelekidis, B A Barbara Silver, Rebecca Gelman, Stuart J. Schnitt, Susan C. Lester
Publikováno v:
Cancer. 85:427-431
Department of Pathology, Brigham and Women’sHospital, Boston, Massachusetts.Presented in part at the 39th annual meeting of theAmerican Society for Therapeutic Radiology andOncology, Orlando, Florida, October 20, 1997.Current address for Janice A.
Autor:
Lindsey Schneider, James L. Connolly, Gloria Peiro, Abram Recht, Smitha V. Gollamudi, J.R. Harris, Rebecca Gelman, J B A Barbara Silver, Stuart J. Schnitt
Publikováno v:
Cancer. 79:1362-1369
BACKGROUND Synchronous bilateral breast carcinoma (SBBC) is an uncommon presentation, and the management of patients with this disease is not well established. METHODS In order to evaluate whether patients with early-stage SBBC could be safely and ef
Autor:
Abram Recht, Jay R. Harris, Susan L. Troyan, B A Barbara Silver, Irene Gage, James L. Connolly, Stuart J. Schnitt, Timothy Eberlein, Rebecca Gelman, Susan M. Love, Asa J. Nixon
Publikováno v:
Cancer. 78:1921-1928
BACKGROUND The relationship between the microscopic margins of resection and ipsilateral breast recurrence (IBR) after breast-conserving therapy for carcinomas with or without an extensive intraductal component (EIC) has not been adequately defined.
Autor:
Irene Gage, Jay R. Harris, Stuart J. Schnitt, James L. Connolly, Rebecca Gelman, Stella Hetelekidis, Asa J. Nixon, B A Barbara Silver, Abram Recht, Bruce Bornstein
Publikováno v:
Cancer. 78:1426-1431
BACKGROUND Although histologic grade has previously been described as a predictor of distant failure, it is uncertain whether histologic grade should be used to decide which patients should undergo axillary lymph node dissection and whether grade sho
Autor:
Timothy J. Eberlein, Robert T. Osteen, Patti Cohen, Susan M. Love, Stuart J. Schnitt, Lindsey Schneider, Jay R. Harris, Kathleen Mayzel, James L. Connolly, M.P.H. Asa J. Nixon M.D., James Hayman, B A Barbara Silver, Abram Recht, Susan Pierce, Rebecca Gelman
Publikováno v:
Cancer. 77:1094-1100
BACKGROUND Randomized clinical trials have clearly demonstrated that the use of radiation therapy (RT) following breast-conserving surgery (CS) substantially reduces the risk of local recurrence. However, the low rate of local recurrence after CS and
Publikováno v:
Cancer. 74:708-714
Background. The cellular composition of nodular sclerosis Hodgkin's disease (NS-HD) varies greatly from patient to patient. It is unclear whether subclassifying NS-HD based on cellular composition has prognostic value, because reported studies examin
Publikováno v:
Cancer. 72:249-255
Background. The optimal treatment for Stage IV Hodgkin disease (HD) remains uncertain, particularly the role of radiation therapy (RT). Methods. A retrospective review of 43 children, 18 years of age or younger, who were seen and treated for Stage IV
Autor:
David S. Rosenthal, B A Barbara Silver, George Canellos, C. Norman Coleman, Peter Mauch, Lawrence N. Shulman, Minoru Uematsu, Nancy J. Tarbell, Howard Weinstein
Publikováno v:
Cancer. 72:207-212
Background. Patients with Hodgkin disease who have relapses after initial chemotherapy (CT) appear to have a poor prognosis, especially if the duration of the first complete remission (CR) was short. The authors performed a retrospective analysis of
Autor:
Xiaochun Li, Abram Recht, Jay R. Harris, Lawrence N. Shulman, Steven E. Come, J B A Barbara Silver, Rebecca Gelman, Jennifer R. Bellon
Publikováno v:
Cancer. 100(7)
BACKGROUND Concurrent administration of chemotherapy and radiotherapy has the potential advantage of delaying neither treatment and providing radiation sensitization. However, the optimal approach to concurrent treatment in women with early-stage bre